This webinar addresses regulatory requirements for investigating out-of-specification (OOS) results, focusing on roles of analysts, supervisors, and quality assurance (QA) personnel, while using a flow chart to explain investigation processes. It aims to help attendees improve handling procedures for OOS situations, highlighting common pitfalls and reviewing recent citations in FDA warning letters. Presented by Danielle Delucy, an experienced professional in quality management, the webinar offers various pricing options for attendance and access.